gut-health

Gut Microbiome Test Flags Cognitive Decline in 35 Adults

Cardiff and Imperial researchers report a stool test separated 35 older adults with mild cognitive impairment from healthy peers, and warn the sample was small

Laboratory research setting representing a published gut microbiome study

Researchers at Cardiff University and Imperial College London report that a stool sample can help tell people with mild cognitive impairment apart from cognitively healthy peers, in a study of 35 older adults published in MedComm on 6 October 2026 and publicised by Cardiff University on 19 October. The team profiled gut bacteria and the chemicals they produce in 18 people with mild cognitive impairment and 17 healthy controls, including 16 cohabiting couples in which one partner had the diagnosis. Participants were recruited through the memory team at Cardiff and Vale University Health Board. Machine learning models combining bacterial and metabolite features separated the two groups with an area under the curve of 0.944, A second signature tracked which of 12 participants declined faster over 12 months of follow-up, scoring 0.867 on gut bacteria alone and 0.956 on metabolites alone. Higher levels of Izemoplasmatales bacteria and the amino acid proline marked the impaired group, alongside lower Ruminococcus, Lachnospira and fumaric acid.

What the authors say about their own numbers

The authors write that the cohort size was limited, increasing the risk of overfitting and potentially inflating the apparent predictive performance of the model, and that the perfect performance of the integrated prognostic model, the version combining both, should be interpreted with caution rather than considered established predictive accuracy. No independent long-term group was available to test the progression signature. Amyloid and tau biomarkers were not measured, so the participants were not confirmed as having Alzheimer's-type disease, and diet was not recorded. The work was funded by the Rosetrees Trust with infrastructure support from the NIHR Imperial Biomedical Research Centre, and the authors declare no conflicts of interest.

What this means for your supplement routine

No supplement was tested here. Anyone who had taken a probiotic or a prebiotic in the four weeks before giving a sample was excluded from both groups, so the findings cannot speak to what those products do. The study belongs to the diagnostics field, where stool and blood tests are being examined as earlier ways to identify risk, and the authors state that confirmation in larger independent groups is needed before any claim of clinical predictive utility can be made. Perqen sells food supplements rather than tests, and the FAQs set out how member pricing works.

How Perqen members save

Perqen membership costs £4.99 a month or £29.99 a year and applies member pricing across the whole catalogue instead of building a margin into each product. The membership page sets out both plans.

This article reports published news and research and is for information only. Food supplements are not a substitute for a varied diet or medical care, and no product mentioned is intended to diagnose, treat, cure or prevent any disease. Speak to your GP or pharmacist before changing what you take, especially if you are pregnant, breastfeeding, or taking prescribed medicines.

Sources